Home Tags Zymeworks

Tag: Zymeworks

Think Globally, Act Globally: The Key Role Global Hubs Play in...

Joe Woolery, B.S., Pharm.D., BCOP -

Phase 3 Zanidatamab Study in First-Line HER2+ Gastroesophageal Adenocarcinoma Enrolls Patients

Peter Hofland -
Zymeworks' detailed understanding of protein dynamics helps the company's research scientists to profile protein hotspots and refine protein engineering approaches. Photo Courtesy Zymeworks.

Zanidatamab Shows Promising Response in First-Line HER2-Positive Gastroesophageal Adenocarcinoma

Editorial Team -
Zymeworks' detailed understanding of protein dynamics helps the company's research scientists to profile protein hotspots and refine protein engineering approaches. Photo Courtesy Zymeworks.

Zymeworks Awarded Best ADC Platform Technology at Annual Event

Peter Hofland -

HER2-Targeted Bispecific Antibody ZW25 Shows Durable Response

Peter Hofland -

LATEST NEWS